Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Heidi N. Bonneau"'
Publikováno v:
Journal of interventional cardiology. 30(5)
Objectives We sought to compare the efficacy and safety of prasugrel and ticagrelor in patients with coronary artery disease undergoing percutaneous coronary intervention (PCI). Background Evidence from randomized head-to-head comparison between pras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d426e393d40fe7ca8152174b7ba9273b
https://pubmed.ncbi.nlm.nih.gov/28804959
https://pubmed.ncbi.nlm.nih.gov/28804959
Publikováno v:
International Journal of Cardiology. 167:2250-2258
The effects of cilostazol added to aspirin and clopidogrel (triple antiplatelet therapy: TAT) on clinical outcomes after drug-eluting stent (DES) implantation are unknown.We conducted a meta-analysis of randomized controlled trials (RCTs) comparing T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b962be30270da6f47b916ddb4e8f19e8
https://doi.org/10.1016/j.ijcard.2012.06.010
https://doi.org/10.1016/j.ijcard.2012.06.010
Publikováno v:
International journal of cardiology. 223
Background Both biodegradable polymer biolimus-eluting stents (BP-BES) and biocompatible durable polymer everolimus-eluting stents (DP-EES) have been developed to decrease the risk of late adverse events. However, their efficacy and safety beyond 1ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0410a1719aeaf07a5a51550634cd92e4
https://pubmed.ncbi.nlm.nih.gov/27634137
https://pubmed.ncbi.nlm.nih.gov/27634137
Publikováno v:
The American Journal of Cardiology. 100:S71-S76
The results of 2 randomized controlled trials of the Endeavor zotarolimus-eluting stent (ZES; Medtronic Vascular, Santa Rosa, CA) were recently reported: ENDEAVOR II, in which the Endeavor stent was compared with the Driver bare metal stent (BMS; Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beda72c5b44e03d9be721e81e836cec8
https://doi.org/10.1016/j.amjcard.2007.08.025
https://doi.org/10.1016/j.amjcard.2007.08.025
Autor:
Jean Fajadet, Yasuhiro Honda, Jeffrey J. Popma, Peter J. Fitzgerald, Yoichiro Hongo, Ryota Sakurai, Masao Yamasaki, Richard E. Kuntz, Heidi N. Bonneau, Peter Zimetbaum, Donald E. Cutlip, Paul G. Yock, William Wijns
Publikováno v:
The American Journal of Cardiology. 100:818-823
Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy Driver stents (ZES) demonstrated significant reductions in target lesion revascularization rate with few apparent adverse events compared with bare metal stents (BMS; uncoated Driver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7336dd76891e9f9059aa597b920ba7a
https://doi.org/10.1016/j.amjcard.2007.04.016
https://doi.org/10.1016/j.amjcard.2007.04.016
Autor:
Peter J. Fitzgerald, Heidi N. Bonneau, Junya Ako, Walter Desmet, Ryota Sakurai, Yasuhiro Honda, David R. Holmes, Ali Hassan, Paul G. Yock, Franz-Josef Neumann
Publikováno v:
American Heart Journal. 154:361-365
Recurrent restenosis may occur after drug-eluting stent implantation for in-stent restenosis (ISR) of bare metal stents (BMSs), especially in areas involving drug-eluting stent gaps.To investigate the details of neointimal progression and luminal nar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c8be044446a81cd1da1c5d7a666eb0
https://doi.org/10.1016/j.ahj.2007.04.023
https://doi.org/10.1016/j.ahj.2007.04.023
Autor:
Martin B. Leon, Yasuhiro Honda, Yoshihiro Morino, Jeffrey W. Moses, Shinjo Sonoda, Paul G. Yock, Junya Ako, Heidi N. Bonneau, Peter J. Fitzgerald, Ali Hassan
Publikováno v:
Journal of the American College of Cardiology. 46:1002-1005
Objectives We sought to identify the frequency of incomplete stent apposition (ISA) in sirolimus-eluting stents (SES) and clarify its findings and clinical sequelae. Background Late-acquired ISA has been reported in bare-metal stents (BMS) and brachy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709077cada8c13e4e01957a0418e5c3f
https://doi.org/10.1016/j.jacc.2005.05.068
https://doi.org/10.1016/j.jacc.2005.05.068
Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation
Autor:
Junya Ako, Mitsuyasu Terashima, Richard E. Kuntz, Ali Hassan, Heidi N. Bonneau, Yasuhiro Honda, Shinjo Sonoda, Paul G. Yock, Martin B. Leon, Jeffrey W. Moses, Yoshihiro Morino, Peter J. Fitzgerald
Publikováno v:
Journal of the American College of Cardiology. 43(11):1959-1963
Objectives We assessed the predictive value of minimum stent area (MSA) for long-term patency of sirolimus-eluting stents (SES) implantation compared to bare metal stents (BMS). Background Although MSA is a consistent predictor of in-stent restenosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44bb1cd68cd8924e36815ed8ebce12be
Autor:
Heidi N. Bonneau, Morton J. Kern
Publikováno v:
Catheterization and Cardiovascular Interventions. 58:391-396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61fd627551e4224adcceb82258da8e5b
https://doi.org/10.1002/ccd.10442
https://doi.org/10.1002/ccd.10442
Autor:
Yasuhiro Honda, Tetsu Yamaguchi, Heidi N. Bonneau, Toru Kataoka, Peter J. Fitzgerald, Paul G. Yock, Takahiko Suzuki, Mamoo Nakamura
Publikováno v:
The American Journal of Cardiology. 91:6-11
Deep vessel wall injury is believed to affect vessel dimension following coronary intervention. The cutting balloon is designed to treat coronary artery stenoses with dilatation and surgical incisions, thereby reducing excess vessel injury. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::401a2259e92865e836f22223d0328f2f
https://doi.org/10.1016/s0002-9149(02)02989-2
https://doi.org/10.1016/s0002-9149(02)02989-2